World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615000613505
Date of registration: 12/06/2015
Prospective Registration: Yes
Primary sponsor: Murdoch University
Public title: 12 weeks of exercise training and its effect on immune function and glucose regulation.
Scientific title: In overweight/obese males, does exercise intensity (high-intensity interval training vs continuous moderate-intensity) have an influence on immune function and glucose regulation?
Date of first enrolment: 30/06/2015
Target sample size: 40
Recruitment status: Not yet recruiting
URL:  https://anzctr.org.au/ACTRN12615000613505.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Mr Aaron Raman   
Address:  REF3.001, Refectory building, Murdoch University, 90 South Street, Murdoch WA 6150 Australia
Telephone: +61893601389
Email: A.Raman@Murdoch.edu.au
Affiliation: 
Name: Mr Aaron Raman   
Address:  REF3.001, Refectory building, Murdoch University, 90 South Street, Murdoch WA 6150 Australia
Telephone: +61893601389
Email: A.Raman@Murdoch.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: BMI > 25
Sedentary

Exclusion criteria: Previously diagnosed with Type 2 diabetes
Have an inflammatory disease
Taking medication that may affect blood pressure, glucose control and/or cholesterol.


Age minimum: 18 Years
Age maximum: 44 Years
Gender: Males
Health Condition(s) or Problem(s) studied
Metabolic and Endocrine - Diabetes
Prevention of type 2 diabetes/prediabetes ;Overweight/obesity;
Prevention of type 2 diabetes/prediabetes

Overweight/obesity
Inflammatory and Immune System - Normal development and function of the immune system
Intervention(s)
Exercise training consisting of either:
High intensity exercise (HIT) or continuous moderate-intensity (CME)

HIT - 6 bouts of high-intensity intermittent exercise @ 100% VO2max, on a stationary cycle ergometer with a work-to-rest ratio of 1:4 over a period of 30-minutes. Active recovery consists of cycling @ 50% VO2max and performance will be monitored on the software associated with the cycle ergometer.

CME - Moderate-intensity exercise @ 60% VO2max over a period of 30-minutes on a stationary cycle ergometer.

3 sessions per week
12 weeks
Group session
The researcher will administer the intervention. Dr. Timothy Fairchild is an ESSA Accredited Exercise Physiologist and Aaron Raman is a PhD student in exercise science.

Exercise adherence will be noted with an exercise log.
Primary Outcome(s)
Glucose control via an oral glucose tolerance test and continuous glucose monitor
Insulin sensitivity via serum insulin[Baseline, halfway (week 6) and post-training (week 12).]
Secondary Outcome(s)
Inflammatory markers; pro- and anti-inflammatory markers such as IL-6, CRP and IL-10.[Baseline, halfway (week 6) and post-training (week 12).
Blood samples will be collected in a fasted state.]
Secondary ID(s)
none.
Source(s) of Monetary Support
McCusker Grant
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Murdoch University Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history